Lv01
0 积分 2023-10-13 加入
IBD Clinical
2小时前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
2小时前
已完结
AB1410 EARLY SYMPTOMATIC IMPROVEMENT WITH GUSELKUMAB INDUCTION TREATMENT IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
7小时前
求助中
913b THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
7小时前
已完结
Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection
22天前
已完结
Dietary arachidonic and oleic acid intake in ulcerative colitis etiology
24天前
已完结
Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis
24天前
已完结
The role of fatty acids in Crohn's disease pathophysiology – An overview
24天前
已完结
A little ER stress isn’t bad: the IRE1α/XBP1 pathway shapes ILC3 functions during intestinal inflammation
1个月前
已完结
The IBD Clinic of Tomorrow: Holistic, Patient-Centric, and Value-based Care
1个月前
已完结
皖公网安备34019202002308
